Activated matriptase as a target to treat breast cancer with a drug conjugate
نویسندگان
چکیده
منابع مشابه
Bioinformatics-Based Prediction of FUT8 as a Therapeutic Target in Estrogen Receptor-Positive Breast Cancer
Abstract Introduction: Estrogen receptor-positive (ER-positive) breast cancer is a subgroup of breast tumors that is more likely to respond to hormone therapy. ER-positive and ER- negative breast cancers tend to show different patterns of metastasis because of different signaling cascade and genes that are activated by estrogen response. Genetic factors can contribute to high rates of metastas...
متن کاملBioinformatics-Based Prediction of FUT8 as a Therapeutic Target in Estrogen Receptor-Positive Breast Cancer
Abstract Introduction: Estrogen receptor-positive (ER-positive) breast cancer is a subgroup of breast tumors that is more likely to respond to hormone therapy. ER-positive and ER- negative breast cancers tend to show different patterns of metastasis because of different signaling cascade and genes that are activated by estrogen response. Genetic factors can contribute to high rates of metastas...
متن کاملP14: Mitochondria as a Target for Drug Therapy in Epilepsy
لطفاً به چکیده انگلیسی مراجعه شود.
متن کاملCOVID-19 as a Threat to Various Aspects of the Health of Women with Breast Cancer
COVID-19 as a Threat to Various Aspects of the Health of Women with Breast Cancer
متن کاملRelationship of Attachment Styles to God and Depression with Death Anxiety as a Mediator among Women with Breast Cancer
Background and Purpose: Breast cancer, which accounts for a high mortality rate due to cancer, is the most common cancer in females. Since this disease has negative effects on life, it can lead to depression. Therefore, this study aimed to investigate the relationship of attachment styles to God and depression in females suffering from breast cancer with death anxiety as a mediator. Materials ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Oncotarget
سال: 2018
ISSN: 1949-2553
DOI: 10.18632/oncotarget.25414